Conditions: COPD; LUNG DISEASES, OBSTRUCTIVE
Interventions: Device: Handihaler-Tiotropium 18 mcg untrained; Device: Handihaler-Tiotropium 18 mcg trained; Device: Respimat-Tiotropium 5 mcg trained
Sponsors: Imperial College London; Boehringer Ingelheim
Not yet recruiting – verified October 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days